Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy.

Saved in:
Bibliographic Details
Title: Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy.
Authors: Watts J; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Madarang E; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Abbott D; Department of Biostatistics and Informatics, University of Colorado, Aurora, CO., Hart P; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Sohalski C; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Zoso A; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Dell-Martin J; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Belachew A; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Amaya ML; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Kent A; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., McMahon C; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Schwartz M; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Smith C; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Bradley T; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Taylor J; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Chandhok N; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Venugopal S; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Jordan C; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Berg M; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Haag M; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Willard N; Department of Pathology, Children's Hospital Colorado, Aurora, CO., Aisner D; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Schowinsky J; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Pan Z; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Zhang J; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Gutman JA; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Pollyea DA; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO. Daniel.pollyea@ucdenver.edu.
Source: Haematologica [Haematologica] 2026 Feb 26. Date of Electronic Publication: 2026 Feb 26.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1592-8721
DOI:10.3324/haematol.2025.300374